Icade (CDMGF)
| Market Cap | 1.31B -27.3% |
| Revenue (ttm) | 1.51B -1.5% |
| Net Income | -213.87M |
| EPS | -2.77 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 5.49 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Open | 16.62 |
| Previous Close | 20.15 |
| Day's Range | 16.62 - 16.62 |
| 52-Week Range | 16.62 - 25.90 |
| Beta | 0.90 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 9, 2027 |
About Icade
Icade is a real estate player that strives to make cities more pleasant places to live for everyone. Icade combines expertise in property investment (portfolio worth 6.1bn euros as of 12/31/2025 100% + Group share of joint ventures) and property development (2025 economic revenue of 1.1bn pounds), supporting clients, elected officials and partners throughout France in building the city of tomorrow. A city more respectful of nature and more aligned with the way we live, work and travel. Icade is listed as an on Euronext Paris, with the Caisse de... [Read more]
Financial Performance
In 2025, Icade's revenue was 1.34 billion, a decrease of -5.33% compared to the previous year's 1.41 billion. Losses were -123.00 million, -55.42% less than in 2024.
Financial numbers in EUR Financial StatementsNews
Icade Earnings Call Transcript: Q3 2026
9M revenue declined 3.9% YoY amid subdued leasing and residential demand, while 2026 cash flow guidance was maintained. Asset disposals, disciplined financing and the proposed scrip dividend support balance-sheet flexibility.
Icade Earnings release: Q3 2026
Icade released its Q3 2026 earnings on October 21, 2026, summarizing the period's financial results.
Icade Slides: Q3 2026
Icade has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 21, 2026.
Icade downgraded to Underperform from Hold at Jefferies
Jefferies downgraded Icade (CDMGF) to Underperform from Hold with a price target of EUR 12, down from EUR 19. The EU real estate sector “can handle the debt,” but the…
Icade price target lowered to EUR 21 from EUR 23 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Icade (CDMGF) to EUR 21 from EUR 23 and keeps an Equal Weight rating on the shares.
Icade price target lowered to EUR 30.80 from EUR 33.40 at Citi
Citi lowered the firm’s price target on Icade (CDMGF) to EUR 30.80 from EUR 33.40 and keeps a Buy rating on the shares.
Icade Earnings Call Transcript: Q2 2026
Disposals and strategic acquisitions strengthened the balance sheet, with resilient operating performance and improved residential development margins. Guidance for 2026 is confirmed, though macro and political uncertainties persist.
Icade Earnings release: Q2 2026
Icade released its Q2 2026 earnings on July 22, 2026, summarizing the period's financial results.
Icade Quarterly report: Q2 2026
Icade has published its Q2 2026 quarterly earnings report on July 22, 2026.
Icade Slides: Q2 2026
Icade has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 22, 2026.
Icade Slides: FY 2026
Icade has posted slides in relation to its FY 2026 quarterly earnings report, which was published on June 10, 2026.
Icade upgraded to Hold from Reduce at Kepler Cheuvreux
Kepler Cheuvreux analyst Benjamin Legrand upgraded Icade (CDMGF) to Hold from Reduce with a price target of EUR 22, up from EUR 20. The firm sees more limited downside at…
Icade Earnings Call Transcript: Q1 2026
Liquidity and LTV improved after a major asset disposal, but revenue and rental income declined year-on-year. Property development slowed in March amid market volatility, while 2026 guidance is reaffirmed despite geopolitical uncertainty.
Icade Earnings release: Q1 2026
Icade released its Q1 2026 earnings on April 17, 2026, summarizing the period's financial results.
Icade Slides: Q1 2026
Icade has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 17, 2026.
Icade downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Ana Escalante downgraded Icade (CDMGF) to Equal Weight from Overweight with a price target of EUR 25, down from EUR 30. The firm says disposal of the…
Icade Earnings Call Transcript: Q4 2025
2025 saw robust operational execution, record disposals, and disciplined capital management, despite revenue and asset value declines. 2026 is expected to be the low point for cash flow, with gradual recovery anticipated and a focus on selective investment and cost control.
Icade Slides: Q4 2025
Icade has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 18, 2026.
Icade Annual report: Q4 2025
Icade has published its Q4 2025 annual report on February 18, 2026.
Icade Earnings release: Q4 2025
Icade released its Q4 2025 earnings on February 18, 2026, summarizing the period's financial results.
Icade downgraded to Reduce from Hold at Kepler Cheuvreux
Kepler Cheuvreux downgraded Icade (CDMGF) to Reduce from Hold.
Icade price target lowered to EUR 21 from EUR 22 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Icade (CDMGF) to EUR 21 from EUR 22 and keeps a Hold rating on the shares.
Icade Earnings Call Transcript: Q3 2025
Disposals totaling €430 million and strong leasing activity supported improved occupancy rates, despite a 9% revenue decline and challenging market conditions. 2025 guidance for Net Current Cash Flow is reaffirmed, with a cautious outlook for 2026 amid political and economic headwinds.
Icade Earnings release: Q3 2025
Icade released its Q3 2025 earnings on October 23, 2025, summarizing the period's financial results.
Icade Slides: Q3 2025
Icade has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 23, 2025.